Adeno-associated virus vectors can be efficiently produced without helper virus
Tadashi Matsushita, Susan S. Elliger, CA Elliger et al. · Gene Therapy · 1998
Cited by 500 works. doi:10.1038/sj.gt.3300680
Authors
- Tadashi Matsushita
- Susan S. Elliger
- CA Elliger
- Gregory M. Podsakoff
- Luis P. Villarreal
- Gary J. Kurtzman
- Y Iwaki
- P. Colosi
References
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5
- Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain
- Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector
- Transformation of mammalian cells with an amplifiable dominant-acting gene.
- Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors
- Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein
- Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection
- Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus
- Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2α kinase
- Herpes Simplex Virus Types 1 and 2 Completely Help Adenovirus-Associated Virus Replication